The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction

American Heart Journal

Volumn 159, Issue 4, 2010, Pages 672-676

  Ergelen, Mehmet ^a   Gorgulu, Sevket ^b   Uyarel, Huseyin ^c   Norgaz, Tugrul ^b   Aksu, Huseyin ^a   Ayhan, Erkan ^a   Gunaydin, Zeki Yuksel ^a   Isik, Turgay ^a   Tezel, Tuna ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ACIBADEM UNIVERSITY   (Turkey)

^c BALIKESIR UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NITRATE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; FEMALE; HEART INFARCTION; HEART REINFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPERFUSION; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION; STENT THROMBOSIS; SUDDEN DEATH; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 77950180857     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.12.032     Document Type: Article

References (20)

1. Doyle B., Rihal C.S., O'Sullivan C.J., et al. Outcomes of stent thrombosis and restenosis during extended follow up of patients treated with bare-metal coronary stents. Circulation 116 (2007) 2391-2398
2. Stone G.W., Ellis S.G., Colombo A., et al. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation 115 (2007) 2842-2847
3. Antman E.M., Hand M., Armstrong P.W., et al. Canadian Cardiovascular Society; American Academy of Family Physicians; American College of Cardiology; American Heart Association. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 51 (2008) 210-247
4. Wenaweser P., Rey C., Eberli F.R., et al. Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J 26 (2005) 1180-1187
5. Burzotta F., Parma A., Pristipino C., et al. Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTİMİST study. Eur Heart J 29 (2008) 3011-3021
6. Rasoul S., Ottervanger J.P., de Boer M.J., et al., on behalf of the Zwolle Myocardial Infarction Study Group. Predictors of 30 day and 1 year mortality after primary percutaneous coronary intervention for ST elevation myocardial infarction. Coron Artery Dis (2009) (Epub ahead of print)
7. Parodi G., Memisha G., Bellandi B., et al. Effectiveness of primary percutaneous coronary interventions for stent thrombosis. Am J Cardiol 103 (2009) 913-916
8. Chechi T., Vecchio S., Vittori G., et al. ST segment elevation myocardial infarction due to early and late stent thrombosis. J Am Coll Cardiol 51 (2008) 2396-2402
9. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., et al. Academic Research Consortium. Clinical end points in coronary stent trials. A case for standardized definitions. Circulation 115 (2007) 2344-2351
10. Parodi G., Valenti R., Carrabba N., et al. Long term prognostic implications of non-optimal primary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv 68 (2006) 50-55
11. Stevens L.A., Coresh J., Greene T., et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354 (2006) 2473-2483
12. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug eluting stents. JAMA 293 (2005) 2126-2130
13. Hasdai D., Garrat K.N., Holmes Jr. D.R., et al. Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol 28 (1996) 361-367
14. Casserly I.P., Hasdai D., Berger P.B., et al. Usefulness of abciximab for treatment of early coronary artery stent thrombosis. Am J Cardiol 82 (1998) 981-985
15. Sharma M., and Yeghiazarians Y. Stent thrombosis-a complication best avoided. J Invasive Cardiol 20 (2008) 166-167
16. Lemesle G., de Labriolle A., Bonello L., et al. Impact of thrombus aspiration use for the treatment of stent thrombosis on early patient outcomes. J Invasive Cardiol 21 (2009) 210-214
17. Cutlip D.E., Baim D.S., Ho K.K., et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2001) 1967-1971
18. Sadeghi H.M., Stone G.W., Grines C.L., et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108 (2003) 2769-2775
19. Hochman J.S., Sleeper L.A., Webb J.G., et al., SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. Should we emergently revascularize occluded coronaries for cardiogenic shock?. N Engl J Med 341 (1999) 625-634
20. Wiviott S.D., Braunwald E., McCabe C.H., et al. Intensive oral antiplatelet therapy for reduction of ischemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRİTON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet 371 (2008) 1353-1363